STOCK TITAN

KORU Medical Systems insider disposes of 43,208 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

KORU Medical Systems, Inc. director and 10% owner Joseph M. Manko Jr. and 10% owners Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, L.P. are listed as reporting persons. Horton Capital Partners Fund, L.P. reported an indirect disposition of 43,208 common shares on November 20, 2026, at a reported price of $0.0000 per share. The fund reported 5,031,452 shares following the transaction; a separate direct holding entry listed 782,547 shares.

Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.
Role Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner
Type Security Shares Price Value
Other Common Stock F1, F2 43,208 $0.00 $0.00
Holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 5,031,452 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 782,547 shares (Direct)
Footnotes (2)
  1. F1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
  2. F2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
Common shares disposed 43,208 shares Indirect disposition by Horton Capital Partners Fund, L.P. on November 20, 2026
Reported price per share $0.0000 per share For the reported disposition on November 20, 2026
Fund shares following transaction 5,031,452 shares Indirect holdings reported following the November 20, 2026 transaction
Direct holding 782,547 shares Separate direct holding entry dated November 20, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KRMD shares did Horton Capital Partners Fund, L.P. dispose of?

Horton Capital Partners Fund, L.P. reported a disposition of 43,208 common shares on November 20, 2026. The reported price was $0.0000 per share, and the fund reported holding 5,031,452 shares following the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.

(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/20/2026J(1)43,208D$05,031,452IBy Horton Capital Partners Fund, LP(2)
Common Stock782,547D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.

(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Management, LLC

(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners, LLC

(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners Fund, L.P.

(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR

(Street)
PHILADELPHIA PENNSYLVANIA 19103

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
/s/ Joseph M. Manko, Jr.11/20/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC11/20/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC11/20/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading